艾迪药业
(688488)
| 流通市值：90.89亿 | | | 总市值：90.89亿 |
| 流通股本：4.21亿 | | | 总股本：4.21亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 341,015,417.63 | 377,619,691.63 | 422,725,438.85 | 335,339,509.95 |
| 交易性金融资产 | 80,183,509.95 | 95,281,566.98 | 30,146,102.56 | 106,183,637.03 |
| 应收票据及应收账款 | 172,183,004.27 | 148,660,950.36 | 156,174,691.95 | 152,031,473.62 |
| 其中：应收票据 | 10,320,941.65 | 7,769,853.48 | 28,829,134.78 | 12,890,146.59 |
| 应收账款 | 161,862,062.62 | 140,891,096.88 | 127,345,557.17 | 139,141,327.03 |
| 应收款项融资 | 31,681,021.7 | 37,437,716.24 | 6,874,888.88 | 10,893,172.4 |
| 预付款项 | 7,831,367.62 | 9,456,376.75 | 8,425,288.74 | 5,600,780.32 |
| 其他应收款合计 | 8,343,290.71 | 13,067,315.61 | 21,389,848.17 | 20,915,633.77 |
| 存货 | 245,852,021.48 | 266,391,336.81 | 271,741,947.75 | 254,971,935.86 |
| 其他流动资产 | 8,700,361.94 | 8,460,737.96 | 5,567,294.29 | 8,995,467.14 |
| 流动资产合计 | 895,789,995.3 | 956,375,692.34 | 923,045,501.19 | 894,931,610.09 |
| 非流动资产: | | | | |
| 长期股权投资 | 461,342.53 | 706,604.47 | 1,299,832.17 | - |
| 其他非流动金融资产 | 77,718,947.25 | 83,534,827.34 | 78,734,332.29 | 69,598,100 |
| 固定资产 | 404,664,453.46 | 409,619,723.98 | 416,738,470.28 | 424,195,808.58 |
| 在建工程 | 1,846,913.09 | 2,401,471.13 | 1,409,380.53 | 2,175,929.2 |
| 使用权资产 | 5,863,423.47 | 6,440,665.7 | 6,990,077.46 | 8,076,312.15 |
| 无形资产 | 159,879,460.23 | 164,891,315.24 | 170,506,891.66 | 175,465,377.26 |
| 开发支出 | 9,558,307.82 | 8,848,586.03 | 8,713,678.52 | 4,940,435.17 |
| 商誉 | 171,616,799.19 | 171,616,799.19 | 171,616,799.19 | 171,616,799.19 |
| 长期待摊费用 | 27,723,489.47 | 29,028,596.99 | 30,337,808.71 | 31,472,080.5 |
| 递延所得税资产 | 86,970,328.89 | 84,021,468.06 | 82,637,537.27 | 83,853,709.98 |
| 其他非流动资产 | 2,849,650 | 3,049,650 | 3,075,750 | 3,237,176.2 |
| 非流动资产合计 | 949,153,115.4 | 964,159,708.13 | 972,060,558.08 | 974,631,728.23 |
| 资产总计 | 1,844,943,110.7 | 1,920,535,400.47 | 1,895,106,059.27 | 1,869,563,338.32 |
| 流动负债: | | | | |
| 短期借款 | 289,004,927.5 | 329,155,468.07 | 280,134,871.79 | 220,504,209.85 |
| 应付票据及应付账款 | 102,788,473.54 | 122,622,355.36 | 135,820,243.8 | 113,262,305.93 |
| 其中：应付票据 | 19,041,003.08 | 24,394,729.23 | 32,327,691.34 | 24,394,310.98 |
| 应付账款 | 83,747,470.46 | 98,227,626.13 | 103,492,552.46 | 88,867,994.95 |
| 合同负债 | 5,732,607.86 | 4,376,351.18 | 9,751,471.03 | 13,082,552.61 |
| 应付职工薪酬 | 16,855,134.46 | 14,658,935.29 | 12,324,020.71 | 19,364,625.48 |
| 应交税费 | 14,035,543.92 | 9,773,349.78 | 10,210,141.91 | 7,932,207.87 |
| 其他应付款合计 | 73,727,002.32 | 81,019,171 | 82,640,082.87 | 82,170,338 |
| 一年内到期的非流动负债 | 119,737,006.26 | 111,277,436.39 | 114,629,766.14 | 173,268,842.19 |
| 其他流动负债 | 10,037,959.76 | 9,092,197.58 | 11,318,393.98 | 19,474,328.23 |
| 流动负债合计 | 631,918,655.62 | 681,975,264.65 | 656,828,992.23 | 649,059,410.16 |
| 非流动负债: | | | | |
| 长期借款 | 71,736,000 | 87,720,000 | 83,331,000 | 90,508,000 |
| 租赁负债 | 4,071,764.02 | 4,896,402.62 | 3,736,001.94 | 3,745,262.87 |
| 递延收益 | 45,542,312.8 | 46,940,325.88 | 48,338,338.97 | 49,736,352.06 |
| 递延所得税负债 | 9,698,108.5 | 10,796,157.2 | 10,408,708.36 | 9,427,038.05 |
| 非流动负债合计 | 131,048,185.32 | 150,352,885.7 | 145,814,049.27 | 153,416,652.98 |
| 负债合计 | 762,966,840.94 | 832,328,150.35 | 802,643,041.5 | 802,476,063.14 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 420,782,808 | 420,782,808 | 420,782,808 | 420,782,808 |
| 资本公积 | 887,921,695.71 | 883,622,921.25 | 883,622,921.25 | 883,622,921.25 |
| 其他综合收益 | 549,789.4 | 549,789.4 | 549,789.4 | 549,789.4 |
| 专项储备 | 962,139.83 | 1,039,928.66 | 1,166,627.71 | 1,286,382.54 |
| 盈余公积 | 9,307,578.93 | 9,307,578.93 | 9,307,578.93 | 9,307,578.93 |
| 未分配利润 | -341,495,080.91 | -325,463,627 | -319,072,605.28 | -334,654,581.53 |
| 归属于母公司股东权益合计 | 978,028,930.96 | 989,839,399.24 | 996,357,120.01 | 980,894,898.59 |
| 少数股东权益 | 103,947,338.8 | 98,367,850.88 | 96,105,897.76 | 86,192,376.59 |
| 股东权益合计 | 1,081,976,269.76 | 1,088,207,250.12 | 1,092,463,017.77 | 1,067,087,275.18 |
| 负债和股东权益合计 | 1,844,943,110.7 | 1,920,535,400.47 | 1,895,106,059.27 | 1,869,563,338.32 |
| 公告日期 | 2025-10-31 | 2025-08-29 | 2025-04-30 | 2025-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |